116 related articles for article (PubMed ID: 32457356)
1. Reply to "COVID-19 in persons with haematological cancers": a focus on myeloid neoplasms and risk factors for mortality.
Fattizzo B; Giannotta JA; Sciumè M; Cattaneo D; Bucelli C; Fracchiolla NS; Onida F; Baldini L; Barcellini W; Iurlo A
Leukemia; 2020 Jul; 34(7):1957-1960. PubMed ID: 32457356
[No Abstract] [Full Text] [Related]
2. Response to "COVID-19 in persons with haematological cancers".
Hatzl S; Eisner F; Schilcher G; Kreuzer P; Gornicec M; Eller P; Brodmann M; Schlenke P; Stradner MH; Krause R; Greinix H; Schulz E
Leukemia; 2020 Aug; 34(8):2265-2270. PubMed ID: 32528043
[No Abstract] [Full Text] [Related]
3. COVID-19 and haematological malignancy: navigating a narrow strait.
Rubinstein SM; Warner JL
Lancet Haematol; 2020 Oct; 7(10):e701-e703. PubMed ID: 32798474
[No Abstract] [Full Text] [Related]
4. COVID-19 in persons with haematological cancers.
He W; Chen L; Chen L; Yuan G; Fang Y; Chen W; Wu D; Liang B; Lu X; Ma Y; Li L; Wang H; Chen Z; Li Q; Gale RP
Leukemia; 2020 Jun; 34(6):1637-1645. PubMed ID: 32332856
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands.
van Doesum J; Chinea A; Pagliaro M; Pasquini MC; van Meerten T; Bakker M; Ammatuna E
Leukemia; 2020 Sep; 34(9):2536-2538. PubMed ID: 32641731
[No Abstract] [Full Text] [Related]
6. Balancing risk and benefit during coronavirus.
Sehn LH
Blood; 2020 May; 135(21):1817. PubMed ID: 32275744
[No Abstract] [Full Text] [Related]
7. SARS-CoV-2 infection anxieties and general population restrictions delay diagnosis and treatment of acute haematological malignancies.
Molica M; Mazzone C; Cordone I; Pasquale A; Niscola P; de Fabritiis P
Br J Haematol; 2020 Jul; 190(1):e5-e8. PubMed ID: 32369605
[No Abstract] [Full Text] [Related]
8. Multiple myeloma and COVID-19.
Dhakal B; D'Souza A; Chhabra S; Hari P
Leukemia; 2020 Jul; 34(7):1961-1963. PubMed ID: 32475990
[No Abstract] [Full Text] [Related]
9. Haematological cancers and the risk of severe COVID-19: Exploration and critical evaluation of the evidence to date.
El-Sharkawi D; Iyengar S
Br J Haematol; 2020 Aug; 190(3):336-345. PubMed ID: 32559308
[TBL] [Abstract][Full Text] [Related]
10. Nosocomial outbreak of SARS-CoV-2 infection in a haematological unit - High mortality rate in infected patients with haematologic malignancies.
Biernat MM; Zińczuk A; Biernat P; Bogucka-Fedorczuk A; Kwiatkowski J; Kalicińska E; Marciniak D; Simon K; Wróbel T
J Clin Virol; 2020 Sep; 130():104574. PubMed ID: 32769026
[TBL] [Abstract][Full Text] [Related]
11. Hematologic parameters in patients with COVID-19 infection: a reply.
Fan BE
Am J Hematol; 2020 Aug; 95(8):E215. PubMed ID: 32339335
[No Abstract] [Full Text] [Related]
12. COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter.
Varma A; Kosuri S; Ustun C; Ibrahim U; Moreira J; Bishop MR; Nathan S; Mehta J; Moncayo D; Heng J; Osman K; Adekola KUA
Leukemia; 2020 Oct; 34(10):2809-2812. PubMed ID: 32801310
[No Abstract] [Full Text] [Related]
13. Risk factors for in-hospital mortality in patients with cancer and COVID-19 - Authors' reply.
Yang K; Sheng Y; Wu B; Wu G
Lancet Oncol; 2020 Sep; 21(9):e408. PubMed ID: 32888458
[No Abstract] [Full Text] [Related]
14. [Practical guidelines for the radiotherapy for patients presented with haematological malignancies in the epidemic COVID-19 situation: International Lymphoma Radiation Oncology Group recommendations].
Kirova Y
Cancer Radiother; 2020 Jun; 24(3):194-195. PubMed ID: 32402596
[No Abstract] [Full Text] [Related]
15. Assessing the impact of lockdown: Fresh challenges for the care of haematology patients in the COVID-19 pandemic.
Willan J; King AJ; Djebbari F; Turner GDH; Royston DJ; Pavord S; Collins GP; Peniket A
Br J Haematol; 2020 Jun; 189(6):e224-e227. PubMed ID: 32369622
[No Abstract] [Full Text] [Related]
16. Routine haematological parameters in COVID-19 prognosis.
Pereyra D; Heber S; Jilma B; Zoufaly A; Assinger A
Lancet Haematol; 2020 Oct; 7(10):e709. PubMed ID: 32976747
[No Abstract] [Full Text] [Related]
17. Risk of COVID-19 in Patients With Cancer-Reply.
Chua MLK; Yu J; Xie C
JAMA Oncol; 2020 Sep; 6(9):1472-1473. PubMed ID: 32614375
[No Abstract] [Full Text] [Related]
18. Managing patients with hematological malignancies during COVID-19 pandemic.
Sahu KK; Cerny J
Expert Rev Hematol; 2020 Aug; 13(8):787-793. PubMed ID: 32580592
[No Abstract] [Full Text] [Related]
19. COVID-19 and haematology-oncology services.
The Lancet Haematology
Lancet Haematol; 2020 Sep; 7(9):e625. PubMed ID: 32853576
[No Abstract] [Full Text] [Related]
20. Treatments for COVID-19: emerging drugs against the coronavirus - reply.
Potì F
Acta Biomed; 2020 Jun; 91(3):ahead of print. PubMed ID: 32921741
[No Abstract] [Full Text] [Related]
[Next] [New Search]
